Full name
BERLIN-CHEMIE / MENARINI POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
BERLIN-CHEMIE / MENARINI POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. ZYGMUNTA SŁOMIŃSKIEGO 4, 00-204 WARSZAWA
TAX ID5212405282
Rate company:
BERLIN-CHEMIE / MENARINI POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5212405282
KRS0000057038
Share capital1,000,000.00 zł
address
UL. ZYGMUNTA SŁOMIŃSKIEGO 4, 00-204 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5212405282
REGON
012655453
KRS
0000057038
Legal form
limited liability company
Register Address
UL. ZYGMUNTA SŁOMIŃSKIEGO 4, 00-204 WARSZAWA
Date of registration in KRS
2001-10-30
Date of commencement of economic activity
2001-10-30
Act signature
RDF/609237/24/172
Pkd codes
46.46.Z - Wholesale of pharmaceutical goods
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
73.11.Z - Advertising agencies activities
82.92.Z - Packaging activities
85.59.B - Other out-of-school forms of education, not elsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL86 1240 6247 1111 0000 4975 9543 
PL95 1240 6247 1111 0000 4974 0466 PL26 1240 6247 1111 0000 4980 3594 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 33,4 | 36,2 | 49,5 | 36,8 |
EBITDA | 34,9 | 37,5 | 50,1 | 33,7 |
Short time liabilities | 84,2 | 79,3 | 124,2 | 56,7 |
Equity capital | 115 | 143,1 | 182 | 27,1 |
Operating profit (EBIT) | 33,8 | 36,3 | 49 | 35 |
Assets | 214,2 | 238,3 | 324,4 | 36,1 |
Net profit (loss) | 26,2 | 28,1 | 38,8 | 38 |
Cash | 0,5 | 0,6 | 0,7 | 17,5 |
Liabilities and provisions for liabilities | 99,3 | 95,2 | 142,4 | 49,7 |
Net income from sale | 682,5 | 754,6 | 867,7 | 15 |
Working assets | 205,8 | 229,9 | 313,6 | 36,4 |
Depreciation | 1,1 | 1,2 | 1,1 | -6,2 |
% | % | % | p.p. | |
Profitability of capital | 22,8 | 19,7 | 21,3 | 1,6 |
Equity capital to total assets | 53,7 | 60,1 | 56,1 | -4 |
Gross profit margin | 4,9 | 4,8 | 5,7 | 0,9 |
EBITDA Margin | 5,1 | 5 | 5,8 | 0,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 45 | 38 | 52 | 14 |
Current financial liquidity indicator | 2.457108497619629 | 2.2346420288085938 | -0,3 | |
Net dept to EBITDA | -0.016398077830672264 | 0.31492701172828674 | 0,3 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Auditor's opinion / report on the audit of the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (3)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
"SOLINEA" sp. z o.o. sp.k.
Ciecierzyn
ADO-MED Sp. z o.o.
Świętochłowice
"FARMEDICA" sp. z o.o.
Warszawa
"MEDILAB" sp. z o.o.
Warszawa
Red Med Poland Sp. z o.o.
Chorzów